Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06072859 · ClinicalTrials.gov registry record · NA

The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT06072859 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06072859, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of the study is to learn about the ease of using a humidified fragrant citrus forest oil, along with a virtual simulation of a forest environment (i.e., with sights and sounds of nature using a personal tablet Surface Pro 3 with headphones, to learn more about how these two aspects of the simulated forest immersion therapy (SFIT) may improve pain, anxiety, blood-pressure, and heart rate related to Axial Spondyloarthritis. The investigators hope to learn how well SFIT may impact pain levels, feelings of calm, as well as blood- pressure and heart rate, and how participants tolerate the experience overall.

Interventions

  • OTHER Humidified Forest Oils
  • OTHER Forest oils and audio-visual forest exposure

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-09-21
Est. Completion 2024-03-31
Phase NA

What the Registry Record Tells You About NCT06072859

The ClinicalTrials.gov registry entry for NCT06072859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Humidified Forest Oils is the first listed.

NCT06072859 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06072859 about?

NCT06072859 is a clinical study titled "The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)". The purpose of the study is to learn about the ease of using a humidified fragrant citrus forest oil, along with a virtual simulation of a forest environment (i.e., with sights and sounds of nature using a personal tablet Surface Pro 3 with headphones, to learn more about how these two aspects of th...

What is the current status of trial NCT06072859?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-09-21. Estimated completion is 2024-03-31.

What interventions are being tested in trial NCT06072859?

The interventions under investigation include: Humidified Forest Oils (OTHER), Forest oils and audio-visual forest exposure (OTHER).

Who is sponsoring clinical trial NCT06072859?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.